Outcome of the Board Meeting-Allotment of Bonus Shares
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.4 pts less than Nifty Microcap 250 and 3.8 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Welcure Drugs & Pharmaceuticals has allotted 11,23,58,200 bonus equity shares of Re. 1 each to shareholders as per the 1:10 ratio (1 bonus share for every 10 held), as approved by the Board on 17th October 2025. The record date for eligibility was 16th October 2025. With this allotment, the company's paid-up equity capital has risen from Rs. 1,12,35,82,000 to Rs. 1,23,59,40,200, an increase of about 10%. Fractional entitlements have been ignored — no cash or shares will be given for fractional portions. The new bonus shares will rank equally with existing shares in all respects.
Each shareholder's share count goes up by 10% with no additional cost, though the share price typically adjusts downward proportionally, leaving the overall value unchanged. This is a capital-structure event and not a sign of new cash inflow for shareholders.